You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金達威(002626.SZ):購買誠信藥業86%股權完成工商變更登記
格隆匯 12-14 16:01

格隆匯 12 月 14日丨金達威(002626.SZ)公佈,公司於2020年12月1日召開了第七屆董事會第十五次會議,審議通過了《關於購買江蘇誠信藥業有限公司86%股權的議案》。同意公司與自然人喻紅忠、卞雨花簽署了《關於江蘇誠信藥業有限公司之投資協議》(與股權轉讓協議合稱“協議”),與安徽豐原藥業股份有限公司、南京冠準投資合夥企業(有限合夥)(“冠準”)、自然人喻豔簽署《關於江蘇誠信藥業有限公司之股權轉讓協議》(與投資協議合稱“協議”),以自有資金3.073億元購買上述出讓方所持有的江蘇誠信藥業有限公司(“誠信藥業”)相應股權。

近日,公司根據協議約定向冠準支付股權轉讓款6443.24萬元,誠信藥業收到啟東市行政審批局下發的《公司准予變更登記通知書》,冠準根據約定完成其持有誠信藥業17.90%股權交割、登記過户等相關工作。此外,公司根據協議約定已向自然人喻紅忠、卞雨花、喻豔支付股權轉讓款。

截至公告日,此次交易涉及的誠信藥業86%股權已過户至公司名下,所涉及的股權工商變更登記手續已辦理完畢。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account